Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Halozyme Therapeutics
HALO
5
eBay
EBAY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -2.06%194.28M | -27.92%60.16M | 0.49%67.9M | -26.67%39.63M | 496.51%26.59M | 3.57%198.37M | 22.53%83.46M | 31.89%67.57M | 42.51%54.04M | -119.57%-6.71M |
Net income from continuing operations | 101.87%52.95M | -15.69%12.65M | 212.72%8.97M | 24.97%20.5M | 289.57%10.83M | -59.98%26.23M | -21.01%15M | -153.91%-7.96M | -25.77%16.4M | -71.28%2.78M |
Operating gains losses | 3.74%-31.21M | 86.37%-2.02M | -220.44%-5.21M | ---15.4M | ---8.58M | -67.72%-32.42M | ---14.8M | 339.69%4.32M | ---- | ---- |
Depreciation and amortization | -2.45%165.54M | -15.41%37.83M | 13.95%44.28M | -2.15%41.69M | -4.07%41.75M | -1.65%169.7M | 2.55%44.72M | -8.15%38.86M | -5.41%42.61M | 4.62%43.52M |
Deferred tax | 36.03%-20.39M | 77.49%-2.58M | 45.76%-5.92M | -128.85%-5.85M | 12.89%-6.04M | -11.73%-31.88M | -70.23%-11.47M | -49.36%-10.92M | 63.28%-2.56M | 7.84%-6.93M |
Other non cash items | 11.80%105.64M | -5.61%23.75M | 1.31%26.21M | 27.84%38.44M | 28.75%17.24M | 39.72%94.49M | -43.54%25.16M | 513.23%25.87M | 189.33%30.06M | 58.34%13.39M |
Change In working capital | -119.42%-105.94M | -176.59%-15.48M | -193.15%-11.97M | -179.41%-44.75M | 48.37%-33.73M | 46.35%-48.28M | 154.32%20.22M | 292.76%12.85M | 20.01%-16.02M | -150.43%-65.33M |
-Change in receivables | -52.53%3.49M | -127.67%-3.1M | -101.47%-89K | -217.80%-9.97M | 190.74%16.66M | 153.83%7.36M | 187.58%11.21M | 161.33%6.04M | 358.74%8.47M | -249.86%-18.36M |
-Change in inventory | -60.63%2.5M | -51.58%3.38M | -172.94%-2.91M | 105.31%87K | 165.34%1.94M | 133.30%6.35M | 254.18%6.97M | 145.13%3.98M | 66.04%-1.64M | -232.81%-2.97M |
-Change in prepaid assets | -4.46%-29.81M | -1.89%-6.86M | 6.71%-8.45M | ---- | ---- | 6.76%-28.54M | ---6.74M | ---9.06M | ---- | ---- |
-Change in payables and accrued expense | -22.61%-49.93M | -927.01%-10.29M | -64.08%6.04M | 2.08%-14.95M | 29.36%-30.73M | -10,055.11%-40.72M | -90.66%1.24M | -12.78%16.8M | -34.41%-15.27M | -101.12%-43.5M |
-Change in other current assets | -542.63%-32.19M | -81.51%1.39M | -33.39%-6.56M | -205.02%-5.42M | -4,202.19%-21.6M | 127.69%7.27M | 387.04%7.53M | 32.12%-4.92M | 1,000.87%5.16M | 96.83%-502K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -2.06%194.28M | -27.92%60.16M | 0.49%67.9M | -26.67%39.63M | 496.51%26.59M | 3.57%198.37M | 22.53%83.46M | 31.89%67.57M | 42.51%54.04M | -119.57%-6.71M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -61.28%-69.84M | -349.25%-18.52M | 42.45%-7.39M | -88.28%-23.38M | 19.33%-20.56M | 46.09%-43.31M | 123.99%7.43M | 55.56%-12.83M | -8,347.62%-12.42M | -25.36%-25.48M |
Net PPE purchase and sale | 6.31%-94.39M | -23.44%-24.61M | 15.07%-21.15M | 7.25%-28.18M | 19.89%-20.44M | 3.68%-100.75M | 35.98%-19.94M | 11.71%-24.91M | -24.52%-30.39M | -22.42%-25.52M |
Net business purchase and sale | -56.57%23.3M | -63.86%4.97M | 13.27%13.58M | ---- | ---- | 112.43%53.64M | --13.76M | 773.42%11.99M | ---- | ---- |
Net investment purchase and sale | --0 | ---- | ---- | ---- | ---- | 96.37%8.01M | ---- | ---- | ---- | ---- |
Net other investing changes | 129.82%1.25M | -80.01%1.12M | 128.75%183K | 100.67%66K | -441.18%-116K | 16.88%-4.2M | 243.27%5.6M | 103.92%80K | -2,708.42%-9.91M | -93.40%34K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -61.28%-69.84M | -349.25%-18.52M | 42.45%-7.39M | -88.28%-23.38M | 19.33%-20.56M | 46.09%-43.31M | 123.99%7.43M | 55.56%-12.83M | -8,347.62%-12.42M | -25.36%-25.48M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -609.29%-267.26M | 5.07%184.83M | -1.14%-53.47M | -87.42%-72.03M | -167.06%-326.58M | 22.47%-37.68M | 74.24%175.91M | -900.76%-52.87M | -12.01%-38.43M | -11.20%-122.29M |
Net issuance payments of debt | -49.07%-82.27M | 56.32%-17.76M | 23.88%-27.14M | 86.30%-2.8M | -183.17%-34.57M | -35.89%-55.19M | -48.17%-40.66M | -838.56%-35.66M | -13.94%-20.44M | 385.42%41.56M |
Cash dividends paid | -1.56%-54.16M | -1.09%-13.33M | -0.52%-13.36M | -2.09%-13.51M | -2.50%-13.96M | -1.29%-53.33M | -1.16%-13.19M | -2.04%-13.29M | 0.29%-13.24M | -2.25%-13.62M |
Net other financing activities | -284.70%-130.83M | -6.02%215.91M | -230.44%-12.97M | -1,071.00%-55.72M | -85.08%-278.06M | 58.61%70.83M | 62.45%229.75M | -134.03%-3.93M | -53.58%-4.76M | -42.79%-150.23M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -609.29%-267.26M | 5.07%184.83M | -1.14%-53.47M | -87.42%-72.03M | -167.06%-326.58M | 22.47%-37.68M | 74.24%175.91M | -900.76%-52.87M | -12.01%-38.43M | -11.20%-122.29M |
Net cash flow | ||||||||||
Beginning cash position | 35.75%458.03M | -54.71%85.6M | -58.77%78M | -26.54%134.84M | 35.75%458.03M | 18.19%337.42M | -3.52%188.99M | -0.21%189.19M | -3.79%183.55M | 18.19%337.42M |
Current changes in cash | -221.67%-142.82M | -15.12%226.47M | 277.44%7.04M | -1,846.88%-55.78M | -107.50%-320.55M | 87.50%117.38M | 93.20%266.8M | -89.07%1.87M | -7.85%3.19M | -60.86%-154.48M |
Effect of exchange rate changes | -287.45%-6.06M | -229.71%-2.91M | 126.47%548K | -143.33%-1.06M | -531.70%-2.64M | 130.29%3.24M | -34.56%2.24M | 80.78%-2.07M | 152.64%2.45M | -53.64%612K |
End cash Position | -32.50%309.15M | -32.50%309.15M | -54.71%85.6M | -58.77%78M | -26.54%134.84M | 35.75%458.03M | 35.75%458.03M | -3.52%188.99M | -0.21%189.19M | -3.79%183.55M |
Free cash flow | 2.33%99.89M | -44.04%35.55M | 9.57%46.75M | -51.61%11.45M | 119.08%6.15M | 12.29%97.62M | 71.83%63.52M | 85.31%42.66M | 74.98%23.66M | -340.10%-32.22M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |